Tech Company Financing Transactions
Inheart Funding Round
On 5/7/2024, Inheart landed $11 million in investment from Elaia Partners, Vesalius Biocapital and Sagana.
Transaction Overview
Company Name
Announced On
5/7/2024
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Undisclosed
Investors
Elaia Partners (Lead Investor)
Vesalius Biocapital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support the commercial expansion of its digital twin of the heart in the US, EU, Asia Pacific, and Middle East markets, as well as the development of new software solutions across the cardiac care continuum.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
IHU Liryc - Ho^pital Xavier Arnozan Avenue du Haut Le´ve^que
Pessac, 33600
France
Pessac, 33600
France
Phone
Website
Email Address
Overview
At inHEART, we are committed to delivering the world's most sophisticated, AI-enabled, digital twin of the heart to advance the care of patients living with cardiac disease. We believe all patients deserve access to world-class expertise that guides and optimizes treatment strategies to support improved clinical outcomes and return patients to full, healthy lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Todor Jeliaskov
Chief Technical Officer
Jean-Marc Peyrat
VP - Sales
David Gareau
Browse more venture capital transactions:
Prev: 5/7/2024: OptMyCare venture capital transaction
Next: 5/7/2024: DwellFi venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs